CellGenic

CellGenic is a cGMP-certified regenerative medicine manufacturer that produces and sells cells, exosomes, and peptides entirely within its own laboratory under ISO 7 and ISO 20387 standards. Its product catalog includes mesenchymal stem cells such as WJ-MSC and MUSE cells, exosome lines including the ExoElite 70 flagship, lyophilized exosomes, sequence-verified peptide vials and pens, nasal sprays, collagenase, and laboratory equipment, with bioidentical hormones in development for 2026. CellGenic operates as a closed, provider-gated B2B platform, meaning pricing and orders are accessible only to verified accounts and products are not sold direct to consumers. The company functions as a vertically integrated regenerative medicine supplier, handling sourcing, characterization, manufacturing, packaging, and cold-chain distribution without white-labeling or third-party intermediaries. It serves verified physicians, clinic owners, medical directors, and researchers across seven markets including Mexico, Argentina, Colombia, Peru, the United States, Panama, and Costa Rica.